WKN: | A2PKMZ |
ISIN: | US6700024010 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Novavax-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 03. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 27,06 | 75,00 | 177,16% |
2 | 2003 | 50,00 | 91,60 | 83,20% |
3 | 2024 | 4,46 | 7,88 | 76,68% |
4 | 2015 | 98,58 | 156,06 | 58,31% |
5 | 2018 | 22,20 | 32,60 | 46,85% |
6 | 2012 | 18,96 | 27,06 | 42,72% |
7 | 2005 | 46,20 | 65,60 | 41,99% |
8 | 2009 | 26,00 | 36,80 | 41,54% |
9 | 2021 | 97,07 | 133,78 | 37,82% |
10 | 2014 | 75,00 | 98,58 | 31,44% |
11 | 2010 | 36,80 | 39,30 | 6,79% |
12 | 2017 | 25,08 | 22,20 | -11,48% |
13 | 2006 | 65,60 | 56,20 | -14,33% |
14 | 2007 | 56,20 | 46,40 | -17,44% |
15 | 2025 | 7,88 | 6,35 | -19,42% |
16 | 2008 | 46,40 | 26,00 | -43,97% |
17 | 2004 | 91,60 | 46,20 | -49,56% |
18 | 2023 | 9,00 | 4,46 | -50,44% |
19 | 2011 | 39,30 | 18,96 | -51,76% |
20 | 2002 | 304,00 | 50,00 | -83,55% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2022 | 133,78 | 9,00 | -93,27% |
2 | 2019 | 32,60 | 3,50 | -89,26% |
3 | 2016 | 156,06 | 25,08 | -83,93% |
4 | 2002 | 304,00 | 50,00 | -83,55% |
5 | 2011 | 39,30 | 18,96 | -51,76% |
6 | 2023 | 9,00 | 4,46 | -50,44% |
7 | 2004 | 91,60 | 46,20 | -49,56% |
8 | 2008 | 46,40 | 26,00 | -43,97% |
9 | 2025 | 7,88 | 6,35 | -19,42% |
10 | 2007 | 56,20 | 46,40 | -17,44% |
11 | 2006 | 65,60 | 56,20 | -14,33% |
12 | 2017 | 25,08 | 22,20 | -11,48% |
13 | 2010 | 36,80 | 39,30 | 6,79% |
14 | 2014 | 75,00 | 98,58 | 31,44% |
15 | 2021 | 97,07 | 133,78 | 37,82% |
16 | 2009 | 26,00 | 36,80 | 41,54% |
17 | 2005 | 46,20 | 65,60 | 41,99% |
18 | 2012 | 18,96 | 27,06 | 42,72% |
19 | 2018 | 22,20 | 32,60 | 46,85% |
20 | 2015 | 98,58 | 156,06 | 58,31% |